Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RUBICON RESEARCH LIMITED Call Transcript 2026

Jan 28, 2026

61525_rns_2026-01-28_c948365b-e40e-4879-ac2d-7a5166e40b95.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [116 x 56] intentionally omitted <==

January 28, 2026

To, The Manager Listing Department BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400001. Scrip Code: 544578

To, The Manager, Listing Department, National Stock Exchange of India Limited, Exchange Plaza, 5[th] floor, C-1 Block G, Bandra Kurla Complex, Bandra (East), Mumbai - 400051 Scrip Symbol: RUBICON

ISIN - INE506V01022

Sub: Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Quarterly Earnings Call

Dear Sir/ Madam,

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the schedule of Earnings Conference Call to be held on Tuesday, February 03, 2026, to discuss the Company’s financial performance for the quarter and nine months ended December 31, 2025, and the way forward. Please find enclosed the Conference Dial-In details.

We request you to kindly take the above information on record.

Thanking you,

Yours faithfully,

For Rubicon Research Limited

(Formerly known as Rubicon Research Private Limited)

DEEPASHR Digitally signed by DEEPASHREE OMKAR TANKSALE DN: c=IN, o=PERSONAL, title=9602, 2.5.4.20=a80b214753a3728a0e066d1b692a eb28c8fdde1958b7190c8f1512294e4c6614, EE OMKAR postalCode=400603, st=Maharashtra, serialNumber=4ab53e9ad917b69cf2009107 23632675c1ef67f880d460105a99c9762ba5e e18, cn=DEEPASHREE OMKAR TANKSALE TANKSALE Date: 2026.01.28 14:46:47 +05'30'

Deepashree Tanksale Company Secretary & Compliance Officer M. No. A28132

Encl.: As above

_____________ Rubicon Research Limited (Formerly known as Rubicon Research Private Limited) Registered Office & R&D Center Manufacturing Plant-I Manufacturing Plant-II MedOne House, B-75, Road No. 33, K-30/4 & 30/5, Additional M.I.D.C., J-4/2, Additional M.I.D.C., Wagle Estate,Thane - 400 604, Ambernath,Thane - 421 506 Satara - 415 004, Maharashtra, India Maharashtra, India Maharashtra, India Tel: 91-22-61414000/50414000 Tel: 0251-7139500 / 3501240 Tel: 02162-240309 / 240463 Fax: 91-22-61414021 Fax: 0251-7139575 Fax 02162-240331 CIN: L73100MH1999PLC119744 Email: [email protected] Website: www.rubicon.co.in

Conference Call Invita�on Quarterly Earnings Call

==> picture [218 x 105] intentionally omitted <==

Earnings Concall for Rubicon Research 3QFY26

Represented by Senior Management

Represented by Senior Management Represented by Senior Management Represented by Senior Management
Mr. Parag Sanche� CEO Mr. Ni�n Jajodia CFO Mr. Sagar Oak SVP Corp. Dev & Strategy
Date: Tuesday – February 3, 2026
Country
Time
India
05:00 PM
07:30 PM
Singapore & Hong Kong
11:30 AM
UK
06:30 AM
USA

Express Login with Diamond Pass CLICK HERE

Call Leader:

Tushar Manudhane - Execu�ve Director – Healthcare (Mo�lal Oswal Financial Services)

Conference dial-in:

Primary Universal Number: +91 22 6280 1149 / +91 22 7115 8050

Interna�onal Toll-Free Numbers:

USA: 18667462133 | UK: 08081011573 Singapore: 8001012045 | Hong Kong: 800964448